Protalix Biotherapeutics Inc. buy melinda
Start price
17.05.17
/
50%
€7.24
Target price
25.05.17
€9.00
Performance (%)
12.85%
End price
25.05.17
€8.17
Summary
This prediction ended on 25.05.17 with a price of €8.17. The prediction had a final performance of 12.85%. melinda has a follow-up prediction for Protalix Biotherapeutics Inc. where he still thinks Protalix Biotherapeutics Inc. is a Buy. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Protalix Biotherapeutics Inc. | -2.464% | -2.464% | -38.196% | -10.556% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
Comments by melinda for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
Gesundheit | Biotechnologie | Israel
(Vom Mitglied beendet)
Current prediction by melinda for Protalix Biotherapeutics Inc.
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
27.12.23
27.12.23
€2.00
27.12.24
27.12.24
-40.90%
04.10.24
04.10.24
Stopped prediction by melinda for Protalix Biotherapeutics Inc.
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.96
02.06.16
02.06.16
€12.00
02.12.16
02.12.16
-22.13%
02.12.16
02.12.16
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€32.52
23.09.13
23.09.13
€40.00
24.03.14
24.03.14
2.15%
24.03.14
24.03.14